UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000035439
Receipt number R000040373
Scientific Title A survey of psychosocial difficulties and growth among Adolescents and Young Adults with cancer
Date of disclosure of the study information 2019/01/04
Last modified on 2022/12/12 19:01:25

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A survey of psychosocial difficulties and growth among Adolescents and Young Adults with cancer

Acronym

SPEC A 1

Scientific Title

A survey of psychosocial difficulties and growth among Adolescents and Young Adults with cancer

Scientific Title:Acronym

SPEC A 1

Region

Japan


Condition

Condition

Adolescents and Young Adults with cancer

Classification by specialty

Hematology and clinical oncology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Narrative objectives is to understand psychosocial difficulties and growth among Adolescents and Young Adults with cancer

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Primary outcome is to reveal psychosocial difficulties and post traumatic growth among Adolescents and Young Adults with cancer

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Other

Interventions/Control_1

questionnaire survey

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

15 years-old <=

Age-upper limit

39 years-old >=

Gender

Male and Female

Key inclusion criteria

1. Patients diagnosed and understanding their cancer.
2. Patients aged 0-39 years at diagnosis.
3. age 15-39 years

Key exclusion criteria

1 patients judged to be ineligible by principal investigator

Target sample size

700


Research contact person

Name of lead principal investigator

1st name Motohiro
Middle name
Last name Matsui

Organization

Tokyo Metropolitan Children's Medical Center

Division name

Pediatric Hematology/Oncology

Zip code

1830869

Address

2-8-29, Musashidai, Fuchushi, Tokyo

TEL

042-300-5111

Email

motohiro_matsui@tmhp.jp


Public contact

Name of contact person

1st name Motohiro
Middle name
Last name Matsui

Organization

Tokyo Metropolitan Children's Medical Center

Division name

Pediatric Hematology/Oncology

Zip code

1830869

Address

2-8-29, Musashidai, Fuchushi, Tokyo

TEL

042-300-5111

Homepage URL

http://www.byouin.metro.tokyo.jp/shouni/tiken/koukaigenkou/h29b-123doctor.pdf

Email

motohiro_matsui@tmhp.jp


Sponsor or person

Institute

Tokyo Metropolitan Children's Medical Center

Institute

Department

Personal name



Funding Source

Organization

Promotion of Cancer Research in Japan

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Tokyo Metropolitan Children's Medical Center

Address

2-8-29, Musashidai, Fuchushi, Tokyo

Tel

052-300-5111

Email

sn_crsc03@tmhp.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東京都立小児総合医療センター


Other administrative information

Date of disclosure of the study information

2019 Year 01 Month 04 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2018 Year 07 Month 18 Day

Date of IRB

2017 Year 12 Month 06 Day

Anticipated trial start date

2018 Year 07 Month 18 Day

Last follow-up date

2023 Year 12 Month 06 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded

2026 Year 12 Month 06 Day


Other

Other related information



Management information

Registered date

2019 Year 01 Month 04 Day

Last modified on

2022 Year 12 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040373


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name